Abingdon Health Plc
ABDXF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.21 | 0.06 | -1.91 | -0.01 |
| FCF Yield | -10.15% | 5.04% | -50.67% | -414.27% |
| EV / EBITDA | -17.86 | -4.58 | -0.79 | -0.29 |
| Quality | ||||
| ROIC | -36.84% | -86.46% | -153.90% | -23.91% |
| Gross Margin | 59.97% | 51.30% | -184.44% | 29.21% |
| Cash Conversion Ratio | 1.31 | -0.29 | 0.36 | 1.85 |
| Growth | ||||
| Revenue 3-Year CAGR | 29.35% | -29.65% | -18.49% | 72.15% |
| Free Cash Flow Growth | -301.18% | 109.95% | 57.79% | -4,707.59% |
| Safety | ||||
| Net Debt / EBITDA | 0.43 | 0.70 | 0.06 | 0.73 |
| Interest Coverage | -24.09 | -47.84 | -175.43 | -23.59 |
| Efficiency | ||||
| Inventory Turnover | 5.57 | 5.99 | 15.10 | 1.04 |
| Cash Conversion Cycle | 61.42 | -81.81 | -87.67 | 450.54 |